Equillium, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EQ Nasdaq 2830 www.equilliumbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Equillium, Inc.

Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists - Apr 8th, 2026 6:30 am
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 2nd, 2026 2:05 pm
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights - Mar 25th, 2026 2:05 pm
Here’s What Roth Capital Thinks of Equillium (EQ) Stock - Mar 24th, 2026 3:38 pm
Equillium to Participate in the 38th Annual Roth Conference - Mar 18th, 2026 6:30 am
Equillium Announces $35 Million Financing with RA Capital Management - Mar 13th, 2026 6:00 am
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference - Feb 25th, 2026 6:30 am
Equillium Conference: EQ504 Targets Ulcerative Colitis Ahead of Mid-Year Phase 1 Start - Feb 13th, 2026 11:28 am
Equillium to Participate in Upcoming Investor Conferences - Nov 20th, 2025 2:35 pm
Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update - Nov 13th, 2025 2:05 pm
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025 - Oct 22nd, 2025 6:00 am
Equillium Announces Leadership and Corporate Updates - Oct 6th, 2025 2:02 pm
Equillium to Participate in the Cantor Global Healthcare Conference 2025 - Aug 29th, 2025 2:03 pm
Trending tickers: Intel, Tilray, monday.com, Equillium and AMC - Aug 12th, 2025 2:44 am
BC-Most Active Stocks - Aug 11th, 2025 8:30 am
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic - Aug 11th, 2025 6:30 am
Spotlight On 3 Promising Penny Stocks With Over $20M Market Cap - Aug 4th, 2025 6:04 am
Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists - May 6th, 2025 6:00 am
Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504 - May 1st, 2025 6:00 am
Equillium Announces Feedback from the U.S. Food and Drug Administration - Apr 24th, 2025 7:00 am